Case Report: Dupilumab as a corticosteroid-sparing adjunct in severe mucocutaneous pemphigus vulgaris with prior avascular necrosis and chronic kidney disease - Quiz - MDSpire

Case Report: Dupilumab as a corticosteroid-sparing adjunct in severe mucocutaneous pemphigus vulgaris with prior avascular necrosis and chronic kidney disease

  • By

  • Qingbi Hu

  • Yalan Yan

  • FengCong Liu

  • Chunshui Yu

  • Linli Liu

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Case Report: Dupilumab as a corticosteroid-sparing adjunct in severe mucocutaneous pemphigus vulgaris with prior avascular necrosis and chronic kidney disease

  • by Qingbi Hu, Yalan Yan, FengCong Liu, Chunshui Yu, Linli Liu

  • June 26, 2026

Related Content

High-frequency ultrasound features of cutaneous hidrocystoma: a case series with imaging-pathology correlation

Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)

ERYXSeg: a hybrid CNN architecture for robust and resource-aware wound segmentation